Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Ltd., known for its cutting-edge medical imaging technology for cancer detection, has appointed Mr. Brett Mitchell as a new Non-Executive Director. With over 15 years of experience in corporate finance across various industries, Mitchell’s expertise is anticipated to guide Imagion Biosystems in its pursuit of market reestablishment and value creation. His appointment is also expected to bring the company into compliance with corporate regulations, potentially leading to the resumption of its stock trading.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.
